» Articles » PMID: 39614124

Characterizing the Evolutionary Dynamics of Cancer Proliferation in Single-cell Clones with SPRINTER

Abstract

Proliferation is a key hallmark of cancer, but whether it differs between evolutionarily distinct clones co-existing within a tumor is unknown. We introduce the Single-cell Proliferation Rate Inference in Non-homogeneous Tumors through Evolutionary Routes (SPRINTER) algorithm that uses single-cell whole-genome DNA sequencing data to enable accurate identification and clone assignment of S- and G2-phase cells, as assessed by generating accurate ground truth data. Applied to a newly generated longitudinal, primary-metastasis-matched dataset of 14,994 non-small cell lung cancer cells, SPRINTER revealed widespread clone proliferation heterogeneity, orthogonally supported by Ki-67 staining, nuclei imaging and clinical imaging. We further demonstrated that high-proliferation clones have increased metastatic seeding potential, increased circulating tumor DNA shedding and clone-specific altered replication timing in proliferation- or metastasis-related genes associated with expression changes. Applied to previously generated datasets of 61,914 breast and ovarian cancer cells, SPRINTER revealed increased single-cell rates of different genomic variants and enrichment of proliferation-related gene amplifications in high-proliferation clones.

Citing Articles

Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER.

Lucas O, Ward S, Zaidi R, Bunkum A, Frankell A, Moore D Nat Genet. 2024; 57(1):103-114.

PMID: 39614124 PMC: 11735394. DOI: 10.1038/s41588-024-01989-z.

References
1.
Hanahan D . Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022; 12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059. View

2.
van Diest P, van der Wall E, Baak J . Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol. 2004; 57(7):675-81. PMC: 1770351. DOI: 10.1136/jcp.2003.010777. View

3.
Feitelson M, Arzumanyan A, Kulathinal R, Blain S, Holcombe R, Mahajna J . Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015; 35 Suppl:S25-S54. PMC: 4898971. DOI: 10.1016/j.semcancer.2015.02.006. View

4.
Beresford M, Wilson G, Makris A . Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res. 2006; 8(6):216. PMC: 1797032. DOI: 10.1186/bcr1618. View

5.
Brown D, Gatter K . Ki67 protein: the immaculate deception?. Histopathology. 2002; 40(1):2-11. DOI: 10.1046/j.1365-2559.2002.01343.x. View